– USA, CA – HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Dr. Wayne Riley (MD) to its Board of Directors.
“We are very honored to have Dr. Riley join HeartFlow’s Board of Directors. His extensive background in clinical medicine, healthcare and healthcare management will prove to be invaluable as we continue to transform the patient experience in coronary care by advancing our unique AI-enabled HeartFlow Analysis,” said ,” said Board Chairman, Bill Weldon.
About Dr. Wayne J. Riley
Dr. Riley is the President of the State University of New York, Downstate Health Sciences University where he also holds academic rank as Professor of Internal Medicine and Health Policy & Management. Dr. Riley is a Commissioner of the U.S. Medicare Payment Advisory Commission, Chair of the Board of Directors of the New York Academy of Medicine, President Emeritus of the 150,000-member American College of Physicians, which is the nation’s largest medical specialty organization, and an elected member of the prestigious National Academy of Medicine. From January 2007 until July 2013, Dr. Riley was the 10th President and CEO of Meharry Medical College. Prior, he served as a corporate officer and member of the senior management team as the VP and Vice Dean for Health Affairs and Governmental Relations and Associate Professor of Internal Medicine at the Baylor College of Medicine in Houston, Texas.
Dr. Riley is an Independent Director of HCA Healthcare, Inc., where he Chairs the Patient Safety & Quality Committee and is a member of the Audit & Compliance and Nominating & Corporate Governance Committees. Additionally, he is an independent director of Compass Pathways, plc, where he serves on the Compensation and Leadership Development and Nominating and Corporate Governance Committees. Dr. Riley previously served as an Independent Director of Vertex Pharmaceuticals and Pinnacle Financial Partners, a community bank holding company, and was a director of the Nashville Branch Bank Board of Directors of the Federal Reserve Bank of Atlanta.
“I am incredibly pleased to serve on the Board of Directors for HeartFlow, especially during this exciting phase of growth,” commented Dr. Riley. “The HeartFlow FFRct Analysis is truly revolutionary, and I look forward to working with the Board and management team to democratize and advance access to this incredible technology for all heart disease patients.”
Dr. Riley earned a Bachelor of Arts from Yale University; a Master of Public Health in Health Systems Management from Tulane University School of Public Health & Tropical Medicine; an MD from the Morehouse School of Medicine and an MBA from Rice University’s Jesse H. Jones Graduate School of Business.
About HeartFlow
HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRct Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.
For more information: https://www.heartflow.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.